Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate whether radiotherapy with carboplatin will result in longer survival than radiotherapy alone in elderly patients with unresectable stage III NSCLC.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Japan Clinical Oncology Group
Collaborators
NCT06487078 · ALK+ Non-Small-Cell Lung Carcinoma
NCT06461338 · Non-small Cell Lung Cancer, Non-Small-Cell Lung Carcinoma
NCT04738487 · Lung Neoplasms, Non-Small-Cell Lung Carcinoma
NCT04990479 · Melanoma (Skin), Non-Small-Cell Lung Carcinoma
NCT03950674 · Non-Small-Cell Lung Carcinoma
Aichi Cancer Center Hospital
Nagoya, Aichi-ken
Aichi Cancer Center,Aichi Hospital
Okazaki, Aichi-ken
National Cancer Center Hospital East
Kashiwa, Chiba
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions